Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 4 studies | 26% ± 9% | |
| GABAergic neuron | 3 studies | 27% ± 9% | |
| glutamatergic neuron | 3 studies | 29% ± 10% | |
| interneuron | 3 studies | 28% ± 14% | |
| astrocyte | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 90.68 | 2597 / 2642 | 49% | 0.75 | 342 / 705 |
| prostate | 100% | 125.47 | 245 / 245 | 34% | 0.52 | 173 / 502 |
| uterus | 100% | 151.64 | 170 / 170 | 27% | 0.42 | 124 / 459 |
| thymus | 100% | 81.50 | 652 / 653 | 26% | 0.52 | 158 / 605 |
| bladder | 100% | 78.71 | 21 / 21 | 23% | 0.35 | 114 / 504 |
| breast | 95% | 56.80 | 435 / 459 | 23% | 0.38 | 262 / 1118 |
| kidney | 99% | 52.46 | 88 / 89 | 12% | 0.16 | 104 / 901 |
| ovary | 100% | 134.58 | 180 / 180 | 10% | 0.15 | 43 / 430 |
| lung | 88% | 42.03 | 511 / 578 | 19% | 0.29 | 219 / 1155 |
| adrenal gland | 94% | 47.60 | 243 / 258 | 11% | 0.15 | 26 / 230 |
| intestine | 99% | 68.57 | 953 / 966 | 6% | 0.08 | 32 / 527 |
| esophagus | 93% | 54.63 | 1348 / 1445 | 11% | 0.16 | 20 / 183 |
| muscle | 100% | 3086.54 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 159.99 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.76 | 1 / 1 |
| skin | 82% | 57.73 | 1477 / 1809 | 18% | 0.26 | 84 / 472 |
| blood vessel | 92% | 40.65 | 1228 / 1335 | 0% | 0 | 0 / 0 |
| heart | 91% | 72.09 | 786 / 861 | 0% | 0 | 0 / 0 |
| adipose | 89% | 43.02 | 1077 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 81% | 31.40 | 292 / 359 | 7% | 0.08 | 19 / 286 |
| pancreas | 74% | 23.66 | 242 / 328 | 13% | 0.17 | 23 / 178 |
| liver | 79% | 31.24 | 179 / 226 | 5% | 0.07 | 19 / 406 |
| peripheral blood | 65% | 24.16 | 602 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 0.45 | 9 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 18% | 0.30 | 8 / 45 |
| eye | 0% | 0 | 0 / 0 | 10% | 0.14 | 8 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0035994 | Biological process | response to muscle stretch |
| GO_0060297 | Biological process | regulation of sarcomere organization |
| GO_0006631 | Biological process | fatty acid metabolic process |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0031674 | Cellular component | I band |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0014704 | Cellular component | intercalated disc |
| GO_0005634 | Cellular component | nucleus |
| GO_0031432 | Molecular function | titin binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000976 | Molecular function | transcription cis-regulatory region binding |
| Gene name | ANKRD23 |
| Protein name | Ankyrin repeat domain-containing protein 23 (Diabetes-related ankyrin repeat protein) (Muscle ankyrin repeat protein 3) |
| Synonyms | DARP |
| Description | FUNCTION: May be involved in the energy metabolism. Could be a molecular link between myofibrillar stretch-induced signaling pathways and muscle gene expression. |
| Accessions | ENST00000418232.5 [Q86SG2-1] Q86SG2 ENST00000318357.9 [Q86SG2-1] ENST00000331001.2 [Q86SG2-2] |
